02/14/2019 /
A recent clinical study explored the effects of ketogenic supplements on delaying oxygen-induced seizures in a preclinical study.
02/14/2019 /
Researchers are working on a method to stimulate the brain using electrodes placed on the head rather than inside it. The goal is to customize treatment for patients with severe epilepsy.
02/14/2019 /
In a new report reinterpreting clinical genomic epilepsy test results, about a third of patients had variants reclassified. This led to a clinically significant change in the interpretation in a third of that cohort.
02/14/2019 /
Polysomnography was effective for identifying patients with undiagnosed sleep-disordered breathing (SDB) in consecutive patients with epilepsy and psychogenic nonepileptic seizures (PNES) who were admitted for inpatient video-electroencephalography monitoring.
02/14/2019 /
Low interictal HCVR may increase the risk of severe respiratory depression and SUDEP after GCS and warrants further study.
02/12/2019 /
These findings indicate that autoantibodies can induce seizures in anti-NMDAR encephalitis and offer a model for testing novel therapies for refractory autoimmune seizures.
02/12/2019 /
In this study, long-term add-on cannabidiol treatment had an acceptable safety profile in patients with Lennox-Gastaut syndrome and led to sustained reductions in seizures.
02/11/2019 /
Subjects mostly favored “person-first” terminology (“person having epilepsy” and “person with epilepsy”), and 53.9% disapproved of the term “epileptic”.
02/11/2019 /
Zogenix, Inc. announced it has completed its rolling submission of a New Drug Application (NDA) to the FDA for FINTEPLA for the treatment of seizures associated with Dravet syndrome.
